News Detail
Mumbai, 19 April 2018: The Uttarakhand Drugs Controller (DC), Tajber Singh has suspended manufacturing licences of around 50 pharmaceutical companies involved in manufacturing of fixed dose combinations (FDCs) without approval from the Drugs Controller General of India (DCGI).
Source : Pharmabiz
Related News
- Fake doctor accused of killing patient due to negligence arrested (29-03-2024)
- CSIR-NIIST develops tech for biomedical waste disposal (29-03-2024)
- Form special grievance cell in each dept: High court to chief secretary (29-03-2024)
- Pharma exports to US up 15% in April-Feb FY24 (29-03-2024)
- Domestic drug firms to witness 8-10% revenue growth in FY25: Report (29-03-2024)
- Essential medicines to cost slightly more from April 1 (29-03-2024)
- How Miltefosine to treat Dermal Kala-azar is Affecting Patients’ Eyesight (28-03-2024)
- Complaint of the Police Inspector is legally invalid: Supreme Court (28-03-2024)
- DTAB recommends excipients causing high sensitivity to be mentioned on drug labels (28-03-2024)
- Antidepressants among 12 drugs fail quality test (28-03-2024)